{
  "resourceType" : "ActivityDefinition",
  "id" : "TP53andDEL17pCLL",
  "meta" : {
    "profile" : ["https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/assessment-action"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ActivityDefinition TP53andDEL17pCLL</b></p><a name=\"TP53andDEL17pCLL\"> </a><a name=\"hcTP53andDEL17pCLL\"> </a><a name=\"TP53andDEL17pCLL-en-US\"> </a><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href=\"ActivityDefinition-TP53andDEL17pCLL.html\">ActivityDefinition FISH hinsichtlich TP53 und DEL17p</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: TP53andDEL17pCLL</p><p><b>title</b>: FISH hinsichtlich TP53 und DEL17p</p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <span title=\"Codes:{http://hl7.org/fhir/fhir-types Patient}\">Patient</span></p><p><b>date</b>: 2025-01-16 09:02:23+0000</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>TP53-Deletions- und Mutationsstatus (FISH hinsichtlich del17p und TP53-Mutationsanalyse ≤ 12 Wochen vor Therapiebeginn)</p>\n</div><p><b>kind</b>: ServiceRequest</p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 103680-5}\">TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method</span></p><p><b>timing</b>: Count 1  times, Once</p></div>"
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
    "valueCode" : "computable"
  },
  {
    "url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
    "valueCode" : "structured"
  }],
  "url" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/TP53andDEL17pCLL",
  "version" : "Langversion 2.01",
  "name" : "TP53andDEL17pCLL",
  "title" : "FISH hinsichtlich TP53 und DEL17p",
  "status" : "active",
  "experimental" : false,
  "subjectCodeableConcept" : {
    "coding" : [{
      "system" : "http://hl7.org/fhir/fhir-types",
      "code" : "Patient"
    }]
  },
  "date" : "2025-01-16T09:02:23+00:00",
  "publisher" : "https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll",
  "description" : "TP53-Deletions- und Mutationsstatus (FISH hinsichtlich del17p und TP53-Mutationsanalyse ≤ 12 Wochen vor Therapiebeginn)",
  "kind" : "ServiceRequest",
  "code" : {
    "coding" : [{
      "system" : "http://loinc.org",
      "code" : "103680-5",
      "display" : "TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method"
    }]
  },
  "timingTiming" : {
    "extension" : [{
      "extension" : [{
        "url" : "contextCode",
        "valueCodeableConcept" : {
          "coding" : [{
            "system" : "http://loinc.org",
            "code" : "63936-9"
          }]
        }
      },
      {
        "url" : "offset",
        "valueRange" : {
          "low" : {
            "value" : -12,
            "system" : "http://unitsofmeasure.org",
            "code" : "wk"
          },
          "high" : {
            "value" : 0,
            "system" : "http://unitsofmeasure.org",
            "code" : "wk"
          }
        }
      }],
      "url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/relative-time"
    }],
    "repeat" : {
      "count" : 1
    }
  }
}